MaxVal’s CRISPR report is now available through Patent LiveScape™, an analysis and reporting service that provides clients with interactive reports which extract actionable and predictive information. By leveraging data sciences best practices, MaxVal has constructed an interactive report that melds different yet related data sources into a comprehensive landscape, allowing the reader to dynamically explore relationships.
What sets MaxVal apart, aside from its novel report delivery methods, are its experienced professionals with expertise that spans multiple domains. The MaxVal team is accustomed to working with complicated data from disparate sources and generating outputs that are pleasing to clients.
“My colleagues and I have been paying close attention to the data science community, and more specifically, the practice of data agnosticism,” says Mark O’Donnell, Vice President of Research and Analytics at MaxVal. “While patents provide us with important insights, they are just a small piece of the overall puzzle when it comes to decision making. We try to be inclusive of all data that is available to us, including patents, clinical trials, standards, 510ks, 10ks, products, sentiments, and more. This report is invaluable to those practicing in or investing in the genomics technology space.”
There is a lot of excitement in the research community on the promise of the CRISPR toolbox in genome editing and beyond,” says Ganesh Venkatraman, Manager of Research and Analytics at MaxVal. “Our team has been following the groundbreaking publications, product development, and commercialization efforts related to CRISPR with great interest. Much like the CRISPR toolbox, the Patent LiveScape™ reports are surprisingly simple, versatile and customizable.
MaxVal is a Silicon Valley-based IP solutions provider, known for its cutting-edge products and automated solutions. Since 2004, MaxVal has been providing technology-enabled solutions and expert services to IP professionals, enabling IP counsels and their operations teams to increase efficiencies, scalability and quality.